在性结肠炎中,1调节肠道屏障和免疫反应通过kallikrein kinin系统
Xiang-Qian Dong1, Ying-Hui Zhang2, Juan Luo1
1Department of Gastroenterology, The First Affiliated Hospital of Kunming Medical University, Yunnan Province Clinical Research Center for Digestive Diseases, Kunming 650032, Yunnan Province, China.
World journal of gastroenterology
|February 17, 2025
概括
在性结肠炎 (UC) 模型中的素1 (KRT1) 抗体治疗通过调节卡利克林素系统 (KKS) 来减少炎症和改善肠道屏障功能. KRT1显示了UC的治疗潜力.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 外部因素通过增加结肠上皮的透性和炎症,使性结肠炎 (UC) 恶化.
- 蛋白1 (KRT1) 在这些变化中发挥作用,但其在UC进展中的特定功能需要进一步研究.
研究的目的:
- 研究KRT1在调节UC中的结肠上皮膜透性和炎症中的作用和机制.
- 探索KRT1对卡利克林基因系统 (KKS) 的调节,包括布拉迪基因 (BK) 和高分子量基因因素 (HK) 裂变.
主要方法:
- 在Caco-2细胞中使用KRT1抗体度梯度测试.
- 使用硫酸 (DSS) 诱导的小鼠模型来研究UC.
- 评估了KRT1对KKS激活,BK/HK裂变,肠壁蛋白和炎症性细胞因子的影响.
主要成果:
- KRT1抗体治疗抑制了Caco-2细胞增殖,诱导了细胞亡,改变了BK/HK表达,降低了肠道屏障蛋白的调节.
- 在DSS诱导的小鼠中,给予KRT1抗体减少了结肠损伤,改善了结肠长度,减轻了体重减轻,并抑制了炎症性细胞因子 (IL-1,IL-6,TNF-α).
- KRT1抗体治疗促进了肠道屏障的修复,并减少了DSS引起的结肠损伤.
结论:
- 抑制KRT1可以缓解结肠损伤,并通过抑制炎症性细胞因子和增强肠道屏障功能来维持屏障完整性.
- KRT1在调节结肠上皮质透性和UC炎症方面发挥着重要作用.
- KRT1代表了治疗性结肠炎的潜在治疗标.
更多相关视频
相关概念视频
Inflammatory Bowel Disease I: Ulcerative Colitis
122
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
122
Renewal of Intestinal Stem Cells
2.5K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
2.5K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
524
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
524
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
344
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
344
Chronic Bowel Disorders: Introduction
380
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
380


